Polycystic kidney disease surgery
Polycystic kidney disease Microchapters |
Differentiating Polycystic kidney disease from other Diseases |
---|
Diagnosis |
Treatment |
Case Studies |
Polycystic kidney disease surgery On the Web |
American Roentgen Ray Society Images of Polycystic kidney disease surgery |
Risk calculators and risk factors for Polycystic kidney disease surgery |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: M. Khurram Afzal, MD [2]
Overview
Surgery is not the first-line treatment option for patients with polycystic kidney disease. Surgery is usually reserved for patients with either end stage renal disease (ESRD), recurrent UTI, chronic pain, renal cell carcinoma, chronic hematuria requiring transfusions. Surgical options are either nephrectomy or renal transplant.
Indications
Surgery is not the first-line treatment option for patients with polycystic kidney disease. Surgery is usually reserved for patients with either:[1][2][3]
- End stage renal disease (ESRD)
- Recurrent UTI
- Chronic pain
- Renal cell carcinoma
- Chronic hematuria requiring transfusions
Surgery
- Surgical options are either nephrectomy or renal transplantation.[4]
Contraindications
- Screen for intracranial aneurysm prior to surgery[5]
References
- ↑ Hadimeri H, Nordén G, Friman S, Nyberg G (July 1997). "Autosomal dominant polycystic kidney disease in a kidney transplant population". Nephrol. Dial. Transplant. 12 (7): 1431–6. PMID 9249781.
- ↑ Glassman DT, Nipkow L, Bartlett ST, Jacobs SC (September 2000). "Bilateral nephrectomy with concomitant renal graft transplantation for autosomal dominant polycystic kidney disease". J. Urol. 164 (3 Pt 1): 661–4. PMID 10953121.
- ↑ Fuller TF, Brennan TV, Feng S, Kang SM, Stock PG, Freise CE (December 2005). "End stage polycystic kidney disease: indications and timing of native nephrectomy relative to kidney transplantation". J. Urol. 174 (6): 2284–8. doi:10.1097/01.ju.0000181208.06507.aa. PMID 16280813.
- ↑ Torres VE, Harris PC (July 2009). "Autosomal dominant polycystic kidney disease: the last 3 years". Kidney Int. 76 (2): 149–68. doi:10.1038/ki.2009.128. PMC 2812475. PMID 19455193.
- ↑ Ring T, Spiegelhalter D (December 2007). "Risk of intracranial aneurysm bleeding in autosomal-dominant polycystic kidney disease". Kidney Int. 72 (11): 1400–2. doi:10.1038/sj.ki.5002488. PMID 17882153.